Coeur.AI Screens 5 Conditions via Cloud & AI; Logicboots Joins 3 Accelerators
Logicboots' Coeur.AI merges AI acoustic analysis with a cloud-connected companion app to screen five cardio-respiratory conditions. Backed by three elite accelerators, the platform could set a new standard for SaaS-driven diagnostic tools in under-resourced areas.
Key Takeaways
- Logicboots' Coeur.AI merges AI acoustic analysis with a cloud-connected companion app to screen five cardio-respiratory conditions.
- Backed by three elite accelerators, the platform could set a new standard for SaaS-driven diagnostic tools in under-resourced areas.
Mentioned
Key Intelligence
Key Facts
- 1Logicboots Pvt. Ltd., a Delhi-based deep-tech company, unveiled Coeur.AI, an AI-powered wireless stethoscope, at Viva Technology Paris 2026.
- 2Coeur.AI analyzes heart and lung sounds using advanced acoustic sensing and AI to assist initial screening of pneumonia, tuberculosis, asthma, COPD, and cardiac rhythm abnormalities.
- 3The portable device connects wirelessly to a companion app for digital auscultation and secure data management.
- 4Founders Amit Kumar Singh (CEO) and Swarn lata were inspired by the delayed diagnosis that led to the death of Singh's father, driving a mission to democratize early screening.
- 5Logicboots has been selected for three elite programs: Harvard Foundry Bootcamp, the Sisu Launchpad Accelerator (Top 18 globally), and the Maria 01 Northern Lights Accelerator.
Our mission is to democratize intelligent diagnostics and empower healthcare professionals with affordable AI-enabled tools that can support initial screening and help reduce delays in identifying potential cardio-respiratory conditions.
At the unveiling of Coeur.AI at VivaTech Paris 2026
Coeur.AI targets pneumonia, tuberculosis, asthma, COPD, and cardiac rhythm abnormalities through AI-based auscultation.
Analysis
For SaaS leaders, Coeur.AI is more than a stethoscope—it's a cloud-enabled diagnostic platform that transforms auscultation data into actionable insights. The companion app handles secure data storage, remote collaboration, and could eventually power analytics subscriptions, positioning Logicboots to disrupt the $3B digital cardiology market with a scalable, software-first approach.
Logicboots, a Delhi-based deep-tech startup, has stepped onto the global stage at Viva Technology Paris 2026 with the launch of Coeur.AI, an AI-powered wireless stethoscope designed to screen for a range of cardio-respiratory conditions. The device combines advanced acoustic sensing, embedded electronics, and artificial intelligence to analyze heart and lung sounds, targeting early detection of pneumonia, tuberculosis, asthma, COPD, and cardiac rhythm abnormalities. Announced on June 27, 2026, the unveiling positions Logicboots as a new entrant in the digital health space, where the centuries-old stethoscope is being reimagined through AI and connectivity. Beyond the product itself, the company is attracting international attention through its acceptance into three prestigious startup accelerators—a signal that investors and mentors see potential in its mission to democratize intelligent diagnostics.
The companion app handles secure data storage, remote collaboration, and could eventually power analytics subscriptions, positioning Logicboots to disrupt the $3B digital cardiology market with a scalable, software-first approach.
The global market for AI-based medical devices is expanding rapidly, with the digital stethoscope segment alone projected to exceed $3 billion by 2030. Competitors like Eko and Littmann CORE have already established footholds, but Logicboots aims to differentiate itself with a device that addresses a broader spectrum of conditions and is built explicitly for accessibility in low-resource settings. The founders, Amit Kumar Singh and Swarn lata, were motivated by a personal tragedy: Singh's father died following a delayed diagnosis, an experience common in regions where specialist care is scarce. This origin story gives Coeur.AI a mission-driven edge that resonates with both healthcare providers and impact investors. The device's wireless connectivity and companion app enable digital auscultation and secure data management, potentially allowing remote consultations and continuous monitoring, a feature that aligns with the global shift toward telemedicine and home-based care.
What to Watch
From a startup perspective, Logicboots' trajectory illustrates how deep-tech health startups from emerging markets can gain traction by leveraging international accelerators. The Harvard Foundry Bootcamp, Sisu Launchpad in Helsinki (where Logicboots was among the top 18 global startups), and the Maria 01 Northern Lights Accelerator in the Nordic region—these programs provide not only mentorship and networking but also crucial validation that can open doors to venture funding and pilot partnerships. While no funding figures have been disclosed, the accelerator selections suggest that Logicboots is positioning itself to compete with established players. The tech itself, however, will face rigorous scrutiny; any diagnostic device must prove its clinical efficacy through trials and navigate regulatory pathways like FDA or CE marking, which can take years and millions of dollars. The company's commitment to 'initial screening' rather than diagnosis may help it enter the market with a lower regulatory bar, but it must still demonstrate accuracy and safety.
For the AI and SaaS communities, Coeur.AI embodies the convergence of hardware and cloud-based software. The companion application suggests a platform approach where data can be aggregated, analyzed, and possibly monetized. The AI models trained on acoustic patterns of heart and lung sounds require high-quality, diverse datasets—a challenge in terms of both acquisition and bias mitigation. If Logicboots can build a robust dataset through its accelerator networks and clinical collaborations, it could create a defensible moat. The device's ability to detect multiple conditions from auscultation alone could make it a valuable triage tool in primary care, reducing the burden on overworked healthcare systems. In regions where tuberculosis and pneumonia remain leading causes of death, Coeur.AI could drastically shorten the path from symptom to treatment. As Logicboots expands its global footprint, the interplay between hardware, AI, and cloud infrastructure will likely determine its commercial success. The next 18 months will be critical: clinical validation studies, strategic partnerships, and potential venture rounds will test whether this Delhi startup can translate a deeply personal mission into a sustainable, scalable healthtech business.
Sources
Sources
Based on 4 source articles- indiagazette.comLogicboots Introduces Coeur . AI at VivaTech Paris 2026 , Expanding Its Global Footprint via Leading Startup AcceleratorsJun 27, 2026
- europesun.comLogicboots Introduces Coeur . AI at VivaTech Paris 2026 , Expanding Its Global Footprint via Leading Startup AcceleratorsJun 27, 2026
- calcuttanews.netLogicboots Introduces Coeur . AI at VivaTech Paris 2026 , Expanding Its Global Footprint via Leading Startup AcceleratorsJun 27, 2026
- news.webindia123.comLogicboots Introduces Coeur . AI at VivaTech Paris 2026 , Expanding Its Global Footprint via Leading Startup AcceleratorsJun 27, 2026
Cite This Page
"Coeur.AI Screens 5 Conditions via Cloud & AI; Logicboots Joins 3 Accelerators." SaaS Intelligence Brief, July 25, 2026. https://getsaasbrief.com/story/logicboots-coeurai-cloud-diagnostics-accelerators
How we covered this story
Every story in our saas coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.
Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the saas space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.
Sources are only linked to a story once they clear our classification pipeline at a minimum 35 percent relevance threshold. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
See something wrong in this story — a wrong fact, a broken source link, a misattributed entity? Report a data issue.
| Signal on this page | What it tells you |
|---|---|
| Verified by N sources | Independent corroboration count. N≥2 is our confidence floor; N=1 is marked explicitly. |
| Impact score (1-10) | Regulatory + financial + operational weight. 8+ signals an experienced-operator action item. |
| Sentiment | Five-tier classification trained on labeled saas-specific corpora. |
| Timeline | Where applicable, the related-events sequence that contextualizes today's development. |